Recent Updates
Recently added Catalysts
LLY Positive Sentiment

Lilly to Participate in Guggenheim Oncology Conference Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Oncology Conference on Thursday, Feb. 9, 2023. Jacob Van Naarden, executive vice ...

Friday, February 3, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Eli Lilly and Company is set to participate in the Guggenheim Oncology Conference on February 9, 2023. Key executives, including CEO Jacob Van Naarden, will engage in a fireside chat during the event. An audio webcast will be accessible, providing an opportunity for stakeholders and the public to follow the discussions and insights shared at the conference.
Price reaction · baseline $330.7 (2023-02-02 close) · hit after-hours · 1 other LLY headline(s) in the window, move may be shared
day 0 close · peak
+2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Eli Lilly will share insights at a prominent oncology conference.
  • Participation demonstrates commitment to oncology advancements.
  • Live webcast available allows wider audience engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , Feb. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will participate in the Guggenheim Oncology Conference on Thursday, Feb. 9 , 2023. Jacob Van Naarden, executive vice president and CEO, Loxo@Lilly and David Hyman , M.D., chief medical officer, Loxo@Lilly, will participate in a fireside chat at 10:10 a.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 30 days.
Refer to: Jordan Bishop; [email protected] ; 317-473-5712 (Media)
Joe Fletcher; [email protected] ; 317-296-2884 (Investors)

Frequently Asked Questions

When is Eli Lilly participating in the Guggenheim Oncology Conference?

Eli Lilly will participate on February 9, 2023.

Who will represent Eli Lilly at the conference?

Jacob Van Naarden and David Hyman, M.D. will represent Eli Lilly.

How can I access the conference webcast?

The webcast is available on Lilly's Investor website under 'Webcasts & Presentations.'

Will there be a replay of the presentation?

Yes, a replay will be available for about 30 days on the same website.

ShareAdd on Google
Tags: LLY Viatris Investor Conferences Healthcare Eli Lilly oncology conference Loxo@Lilly investor webcast Jacob Van Naarden
Last updated: Feb 3, 2023

Biotech snapshot

Cash runway
$8950M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DulaglutidePhase 3
Type 2 Diabetes Mellitus →

Catalyst track record

+45%
best trade around LLY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for LLY.

See every catalyst's timing & PoA →